IL-3 is a novel target to interfere with tumor vasculature
Por um escritor misterioso
Descrição
A systematic review of interleukin-2-based immunotherapies in clinical trials for cancer and autoimmune diseases - eBioMedicine
Emerging new therapeutic antibody derivatives for cancer treatment
Targeting angiogenesis in gliomas: Potential role of phytochemicals - ScienceDirect
IL-3 is a novel target to interfere with tumor vasculature
Combination of Epigallocatechin-3-gallate and Silibinin: A Novel Approach for Targeting Both Tumor and Endothelial Cells
Targeting tumor-associated macrophages to synergize tumor immunotherapy
JPM, Free Full-Text
IL-3 is a novel target to interfere with tumor vasculature - Document - Gale Academic OneFile
Targeting the tumor stroma for cancer therapy, Molecular Cancer
de
por adulto (o preço varia de acordo com o tamanho do grupo)
